Why Energy Crashes After Menopause, and How Shilajit Works at the Cellular Level

Quick answer: The energy that disappears after menopause is not about willpower. It is about mitochondria, the small structures inside every cell that produce the fuel your body actually runs on. Estrogen plays a direct role in keeping those structures running efficiently, and when estrogen drops at menopause, cellular power output slows with it. The fulvic acid and trace minerals in shilajit work at that specific layer. Here is what the research shows.

The cellular cause that most conversations miss

Most advice about menopause fatigue focuses on sleep. And yes, the hormonal disruptions that come with perimenopause do affect sleep. But the deeper energy problem, the dragging heaviness that persists even after a full night of rest, has a different origin.

It is inside the mitochondria.

Mitochondria are the power plants of every cell. Through a chain of chemical reactions, they convert glucose and oxygen into adenosine triphosphate, the actual molecule your muscles, your brain, and your organs run on. Estrogen plays a role in regulating mitochondrial biogenesis, which is the process of making new mitochondria and maintaining the efficiency of the ones you have. As estrogen drops at menopause, that regulatory influence weakens. Mitochondria become less numerous and less efficient. They produce less ATP after any demand on them, and they recover more slowly. The result is fatigue that does not fully resolve with rest, because the fatigue is not only about rest. It is about cellular power output.

This is the root that most energy fixes do not reach. Caffeine borrows from your adrenal reserves and leaves a crash. Sleep matters, but even good sleep cannot fully compensate for lower cellular ATP production. Addressing the mitochondrial layer directly is a different approach.

How shilajit works at that layer

Shilajit contains dibenzo-alpha-pyrones, organic compounds found almost exclusively in shilajit that act as electron shuttle molecules inside the mitochondrial membrane. To generate ATP, mitochondria move electrons through a series of protein complexes in what researchers call the electron transport chain. The dibenzo-alpha-pyrones in shilajit are thought to help that process run more smoothly, functioning as additional carriers in the chain and potentially protecting the coenzyme Q10 molecules that move electrons between those protein complexes. A 2014 review of shilajit's human and animal research, by Stohs and colleagues, identified ATP enhancement as one of the compound's core documented effects. https://pubmed.ncbi.nlm.nih.gov/23733436/

Coenzyme Q10, often called CoQ10, is the central electron carrier in mitochondrial ATP production. When CoQ10 is depleted or oxidized, the chain slows and less ATP comes out. The dibenzo-alpha-pyrones are the mechanism by which shilajit is thought to preserve that output, which is what distinguishes it from stimulants that simply override the fatigue signal.

Beyond the dibenzo-alpha-pyrones, shilajit contains more than 80 trace minerals in their naturally chelated form. Many of those minerals serve as essential cofactors for the enzyme complexes that produce ATP. Magnesium is required for every step of glucose metabolism. Zinc is a structural component of mitochondrial enzymes. Selenium is the foundation of the antioxidant systems that protect mitochondrial membranes from the oxidative byproducts of energy production itself. When trace minerals are depleted, the enzymes they support run slower. Many women over 50 are low in one or more of them because food mineral content has decreased, absorption slows with age, and the body's demands do not adjust to meet the reduced supply.

Shilajit delivers those minerals in their humic-chelated form, bound to the fulvic acid carrier that takes them into cells rather than passing through unabsorbed. That is what the "bioavailable mineral" claim means in practical terms.

What the research shows

The most direct research on shilajit and fatigue is a 2012 study by Surapaneni and colleagues, published in the Journal of Ethnopharmacology. Researchers induced chronic fatigue syndrome in rats and then measured the effect of shilajit supplementation. The shilajit group showed reversed behavioral fatigue markers, preserved mitochondrial enzyme activity, and maintained mitochondrial membrane potential, which is the energy gradient that drives ATP production. When mitochondrial membrane potential collapses, ATP production stops. The shilajit group maintained it under sustained stress conditions. https://pubmed.ncbi.nlm.nih.gov/22771318/

That is an animal model, not a human trial, and the limitation is worth naming. What it shows is the mitochondrial mechanism playing out in a controlled setting with measurable outcomes.

The human evidence points in the same direction. A 2019 randomized, controlled trial by Keller and colleagues tested shilajit in 63 active men over 8 weeks at 500 mg per day. The shilajit group preserved maximum muscle strength after a fatigue protocol that reduced strength in the placebo group. It also lowered hydroxyproline, a marker of collagen breakdown in muscle and connective tissue. https://pubmed.ncbi.nlm.nih.gov/30728074/ This is a men-only study, which matters as a limitation when reading it for application to women, but the direction of the fatigue-resistance and muscle-recovery findings is consistent with the animal model.

A 2016 human muscle biopsy study by Das and colleagues took tissue samples from the vastus lateralis muscle before and after 8 weeks of 500 mg per day of shilajit. The analysis found 17 genes in the extracellular matrix and collagen cluster significantly upregulated, some by more than five times. https://pubmed.ncbi.nlm.nih.gov/27414521/ This is a small study at 16 participants, but it shows that shilajit is actively remodeling and supporting muscle tissue at the gene expression level, not sitting inert.

There is no large placebo-controlled trial of shilajit for fatigue in postmenopausal women. The strongest evidence for shilajit in that population remains the 2022 Pingali bone trial, where secondary outcomes showed nitric oxide rising by 50 to 60 percent and oxidative stress markers falling substantially. Both of those changes support better cellular energy production. The fatigue-specific research is mechanistically consistent with those findings but earlier in its development.

Steady energy, not a stimulant

This distinction matters and is worth understanding.

Caffeine works by blocking adenosine receptors in the brain. Adenosine is the molecule that builds up during waking hours and eventually signals fatigue. When caffeine blocks the receptor, the fatigue signal cannot get through, but the adenosine keeps accumulating. When the caffeine wears off, the pent-up adenosine hits at once. The energy was borrowed, not made.

Shilajit does not work on adenosine receptors. It does not interfere with the fatigue signaling system. What it supports is the cellular machinery that actually produces ATP, which means the energy is not borrowed from a reserve that needs to be repaid. It is the difference between turning a generator up versus flipping the breaker back on after the load has tripped it.

The result, when it works, is a different quality than a stimulant. Not a peak with a valley behind it. A steadier baseline that holds through the afternoon because the cell itself is producing more fuel.

The formula

Shilajit is the core energy ingredient in the Trifecta formula, but it helps to understand why the formula includes pearl powder and bamboo silica alongside it.

Pearl powder supplies aragonite calcium, the form of calcium whose mineral structure most closely matches living bone. That same calcium is the electrolyte required for every muscle contraction and every nerve signal. Calcium transients inside mitochondria play a regulatory role in ATP production, signaling the mitochondria to ramp up output when the body is working. A bioavailable, steady calcium supply is part of keeping that signal clean.

Bamboo silica provides silicon, the mineral that crosslinks collagen in connective tissue, muscle fascia, and the structural matrix of every energy-using tissue in the body. Collagen holds muscle fibers in their right geometry, and when that matrix weakens, the tissue cannot generate force as efficiently. Silicon in a form the body can absorb helps maintain the structural integrity of the tissues the mitochondria are powering.

The three ingredients address the energy problem from different angles. The shilajit works at the mitochondrial membrane and through its trace minerals. The pearl supplies the contraction signal. The silica holds the structural matrix together so the effort those cells put out actually produces movement.

What this means for you

The fatigue after menopause is not imaginary and it is not simply a matter of sleeping more. It has a cellular origin in the mitochondrial layer, and the research on shilajit points to that layer as the mechanism worth addressing directly. The animal and human evidence is earlier-stage than the bone trial, but it is directionally consistent, and the underlying mechanism is well established in the biochemistry literature.

If you want to support steady cellular energy rather than borrowing from stimulants, you can find the Optimum Shilajit Trifecta here: https://www.liveoptimum.co/products/optimum-shilajit-trifecta

Frequently asked questions

Why does menopause specifically cause fatigue?

Estrogen plays a role in regulating mitochondrial biogenesis, the process of making new mitochondria and maintaining their efficiency. When estrogen drops at menopause, mitochondrial efficiency declines and cells produce less ATP. This is distinct from fatigue caused by poor sleep alone, though both can overlap and compound.

How is shilajit different from caffeine for energy?

Caffeine blocks adenosine receptors and delays the fatigue signal, which creates a peak followed by a crash when the blocked adenosine hits at once. Shilajit supports the mitochondrial machinery that actually produces ATP, which tends to produce steadier energy without the crash pattern because no reserve is being borrowed.

Is there human research on shilajit and fatigue?

The 2019 Keller randomized controlled trial found that shilajit preserved maximum muscle strength after a fatigue protocol and lowered a connective tissue breakdown marker over 8 weeks. That trial was conducted in men, which is a limitation when reading it directly against women's experience. A 2012 rat model study showed preserved mitochondrial enzyme activity and reversed behavioral fatigue with shilajit supplementation.

How long before energy improves?

The research does not include a specific timeline for fatigue outcomes in women. The Pingali bone trial in postmenopausal women showed blood marker changes beginning around 12 weeks, which gives a general frame for how long shilajit takes to show measurable effects in that population. Energy being a subjective measure, individual timing will vary.

What is the right dose?

The Pingali bone trial used 500 mg per day of purified shilajit and showed the strongest results at that dose. The Keller fatigue trial also used 500 mg per day. That is the standardized dose in the Optimum Trifecta formula.

References

1. Surapaneni DK, et al. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats. Journal of Ethnopharmacology. 2012;143(1):91-99. https://pubmed.ncbi.nlm.nih.gov/22771318/
2. Keller JL, et al. The effects of shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels. Journal of the International Society of Sports Nutrition. 2019;16(1):3. https://pubmed.ncbi.nlm.nih.gov/30728074/
3. Das A, et al. The human skeletal muscle transcriptome in response to oral shilajit supplementation. Journal of Medicinal Food. 2016;19(7):701-709. https://pubmed.ncbi.nlm.nih.gov/27414521/
4. Stohs SJ, et al. Safety and efficacy of shilajit (Mumie). Phytotherapy Research. 2014. https://pubmed.ncbi.nlm.nih.gov/23733436/
5. Pingali U, Nutalapati C. Shilajit extract reduces oxidative stress, inflammation, and bone loss in postmenopausal women: A randomized, double-blind, placebo-controlled trial. Phytomedicine. 2022;105:154334. https://pubmed.ncbi.nlm.nih.gov/35933897/